Abstract | BACKGROUND:
Resistin is a polypeptide hormone secreted by adipose tissue. A prior hospital-based case-control study reported serum resistin levels to be inversely associated with risk of multiple myeloma (MM). To date, this association has not been investigated prospectively. METHODS: We measured resistin concentrations for pre-diagnosis peripheral blood samples from 178 MM cases and 358 individually matched controls from three cohorts participating in the MM cohort consortium. RESULTS: In overall analyses, higher resistin levels were weakly associated with reduced MM risk. For men, we observed a statistically significant inverse association between resistin levels and MM (odds ratio, 0.44; 95% confidence interval (CI) 0.24-0.83 and 0.54; 95% CI 0.29-0.99, for the third and fourth quartiles, respectively, vs the lowest quartile; Ptrend=0.03). No association was observed for women. CONCLUSIONS: This study provides the first prospective evidence that low circulating resistin levels may be associated with an increased risk of MM, particularly for men.
|
Authors | Loredana Santo, Lauren R Teras, Graham G Giles, Stephanie J Weinstein, Demetrius Albanes, Ye Wang, Ruth M Pfeiffer, Qing Lan, Nathaniel Rothman, Brenda M Birmann, Graham A Colditz, Michael N Pollak, Mark P Purdue, Jonathan N Hofmann |
Journal | British journal of cancer
(Br J Cancer)
Vol. 117
Issue 8
Pg. 1241-1245
(Oct 10 2017)
ISSN: 1532-1827 [Electronic] England |
PMID | 28829767
(Publication Type: Journal Article)
|
Chemical References |
- ADIPOQ protein, human
- Adiponectin
- RETN protein, human
- Resistin
|
Topics |
- Adiponectin
(blood)
- Aged
- Australia
(epidemiology)
- Case-Control Studies
- Cohort Studies
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Multiple Myeloma
(blood, epidemiology)
- Multivariate Analysis
- Odds Ratio
- Prospective Studies
- Resistin
(blood)
- Risk
- Sex Factors
- United States
(epidemiology)
|